At 8.6% CAGR, Europe Fill Finish Manufacturing Market is Projected to be Worth US$ 4,772.50 Million by 2030, says Business Market Insights

According to Business Market Insights’ research, the Europe fill finish manufacturing market was valued at US$ 2,473.26 million in 2022 and is expected to reach US$ 4,772.50 million by 2030, registering a CAGR of 8.6% from 2022 to 2030. Significant pipeline for biologics and single-use systems for aseptic fill finish are among the critical factors attributed to the Europe fill finish manufacturing market expansion.             

Aseptic processing will need coordination, risk management, and regulatory compliance as the fill-finish industry grows quickly. In biologics, fill-finish manufacturing is essential to maintaining product integrity, sterility, and regulatory compliance. The potential for biosimilars to reduce biologic medicine costs and improve patient access to care. Biosimilars will open new avenues for innovation and scientific advancement. Therefore, a sizable biologics pipeline in developed regions such as North America and Europe raises the need for fill-finish manufacturing and possibly creates opportunities. For instance, with the state-of-the-art aseptic manufacturing line in Ireland, particularly for liquid and lyophilized biologic vials, as well as with the integration of Allergan's SVP network, AbbVie has further expanded its capability and capacity to more than 40 million units annually.

On the contrary, growing competition in biopharmaceutical contract manufacturing industry hurdles the growth of Europe fill finish manufacturing market. 

Based on product, the Europe fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held 57.8% share of Europe fill finish manufacturing market in 2022, amassing US$ 1,429.45 million. It is projected to garner US$ 2,828.58 million by 2030 to expand at 8.9% CAGR during 2022–2030. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

In terms of modality, the Europe fill finish manufacturing market is categorized into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held 32.0% share of Europe fill finish manufacturing market in 2022, amassing US$ 792.00 million. It is projected to garner US$ 1,590.50 million by 2030 to expand at 9.1% CAGR during 2022–2030.

By end user, the Europe fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held 49.1% share of Europe fill finish manufacturing market in 2022, amassing US$ 1,213.73 million. It is projected to garner US$ 2,405.94 million by 2030 to expand at 8.9% CAGR during 2022–2030.

Based on country, the Europe fill finish manufacturing market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe.  Our regional analysis states that Germany captured 27.4% share of Europe fill finish manufacturing market in 2022. It was assessed at US$ 609.66 million in 2022 and is likely to hit US$ 1,212.80 million by 2030, exhibiting a CAGR of 9.0% during 2022–2030.            

Key players operating in the Europe fill finish manufacturing market are Becton Dickinson and Co, Gerresheimer AG, Groninger and Co GmbH, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Europe NV, NNE AS, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc, among others.

• In October 2023, Stevanato and DWK Life Sciences Sign Non-Exclusive Distribution Agreement for EZ-fill platform products. Stevanato aims to expand distribution of EZ-fill whose proven advantages have turned its processing technology into an industry standard for Ready-To-Use products.
• In July 2023, Syntegon launch its GKF Capsylon 6005 in capsule filling for the nutraceutical industry. It has 360,000 filled capsules per hour thanks to 48 segment bores and two dosing stations. It has higher product yield and minimized dust impact due to patented slide-gate technology.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com